HU CFAR Grand Rounds video recordings

June 8, 2021
HU CFAR Grand Rounds : Cutting Edge Solutions in HIV Research

The Harvard University Center for AIDS Research virtual Grand Rounds series represents an opportunity for Harvard-affiliated HIV researchers and their collaborators to learn about and share high impact, cutting-edge research to the HU CFAR community. If you’re interested in presenting at a future webinar, suggest a topic, or learn more about it, please contact Mark Ingaciola at mark_ingaciola@harvard.edu.

 

January 20, 2022
Global Equity During Pandemics: Lessons from HIV and COVID for Designing a New Paradigm
An HGHI & HU CFAR Collaboration: Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases (NIAID) & John Nkengasong, Director, Africa Centres for Disease Control and Prevention; Nominated Head of U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
Watch on YouTube

 

November 10, 2021
Optimizing PrEP Adherence: What do we know, and what do we need to know?
Ft. Monica Gandhi, MD, MPH (UCSF); Peter Chai, MD (BWH); Christina Psaros, PhD (MGH); Conall O'Cleirigh, PdD (Fenway; MGH); Kenneth Mayer, MD (Fenway)

 

June 4, 2021
Anti-Racism Equity Lens is Needed in Ending the HIV Epidemic
Eliseo J. Pérez-Stable, MD, National Institute on Minority Health and Health Disparities (NIMHD)

 

April 27, 2021
COVID-19 vaccine hesitancy among Black immigrants in the U.S.
Adedotun Ogunbajo, PhD, 
Harvard T.H. Chan School of Public Health

 

April 7, 2021
Emerging science in US Adolescent HIV:Antibodies in acute HIV, long-acting injectables for prevention, study recruitment and retention
Jonathan Hill-Rorie, MPH, 
Fenway Community Health Center; Sybil Hosek, PhD, Cook County Health; Karin Nielsen, MD, Ronald Reagan UCLA Medical Center; UCLA Mattel Children's Hospital; UCLA Santa Monica Medical Center

 

February 26, 2021
Lancet Special Issue: HIV in the United States
Ada Adimora, MD, MPH (UNC); 
Chris Beyrer, MD (Hopkins); Patrick Sullivan, DVM, PhD (Emory); LaRon E. Nelson, PhD, RN, FNP, FNAP, FAAN (Yale); Sally Hodder, MD (U West Virginia); Jennifer Kates, PhD, MPA (Kaiser Family Foundation); Errol Fields, MD, MPH, PhD (Johns Hopkins); Carlos Rodrigues-Diaz, PhD, MPHE, MCHES (GW)

 

January 29, 2021
Forty Years of Solitude: Landmark Results from the S31/A5349 trial of Shortened Treatment for Drug-Susceptible Tuberculosis
Richard Chaisson, MD, 
Johns Hopkins University; Susan Dorman, MD, Medical University of South Carolina; Susan Swindells, MBBS, University of Nebraska Medical Center

 

December 16, 2020
Prevention of HIV and Other Emerging Infections: Things We Have Learned Over 40 Years
Myron S. Cohen, MD, University of North Carolina (UNC) at Chapel Hill

 

October 27, 2020
Antiretrovirals in Pregnancy: the VESTED and Tsepamo Study Results, and Participation of Pregnant Women in Clinical Research
Margaret Little, PhD, Kennedy Institute of Ethic, Georgetown University; Lameck Chinula MD, 
Global Women’s Health, UNC School of Medicine, Rebecca Zash, MD; Beth Israel Deaconess Medical Center; Shahin Lockman, MD, Brigham and Women's Hospital

 

July 30, 2020
"Long-acting Injectable Cabotegravir for HIV Pre-exposure Prophylaxis: What we know, What we don’t know, What we need to know for public health impact”
Raphael J. Landovitz, MD MSc, University of California